| 288.63 -0.19 (-0.07%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 383.32 | 1-year : | 414.49 |
| Resists | First : | 328.18 | Second : | 354.88 |
| Pivot price | 292.43 |
|||
| Supports | First : | 285.01 | Second : | 237.12 |
| MAs | MA(5) : | 288.82 |
MA(20) : | 297.85 |
| MA(100) : | 319.27  |
MA(250) : | 0 | |
| MACD | MACD : | -8.4 |
Signal : | -8.2 |
| %K %D | K(14,3) : | 8.3 |
D(3) : | 8 |
| RSI | RSI(14): 38.4 |
|||
| 52-week | High : | 354.88 | Low : | 230.05 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PODD ] has closed above bottom band by 28.4%. Bollinger Bands are 50.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 290.8 - 292.23 | 292.23 - 293.39 |
| Low: | 282.65 - 284.62 | 284.62 - 286.22 |
| Close: | 285.88 - 288.85 | 288.85 - 291.27 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Fri, 26 Dec 2025
3 Reasons Growth Investors Will Love Insulet (PODD) - sharewise.com
Thu, 25 Dec 2025
Insulet Corporation $PODD Holdings Decreased by Squarepoint Ops LLC - MarketBeat
Wed, 24 Dec 2025
Insulet Corporation $PODD Shares Acquired by Munro Partners - MarketBeat
Tue, 23 Dec 2025
Patton Fund Management Inc. Buys 13,972 Shares of Insulet Corporation $PODD - MarketBeat
Mon, 22 Dec 2025
Insulet Corporation's (NASDAQ:PODD) Business Is Yet to Catch Up With Its Share Price - 富途牛牛
Mon, 22 Dec 2025
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 70 (M) |
| Shares Float | 70 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 101.1 (%) |
| Shares Short | 2,090 (K) |
| Shares Short P.Month | 1,830 (K) |
| EPS | 3.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.68 |
| Profit Margin | 9.7 % |
| Operating Margin | 16.6 % |
| Return on Assets (ttm) | 8.7 % |
| Return on Equity (ttm) | 19.6 % |
| Qtrly Rev. Growth | 29.8 % |
| Gross Profit (p.s.) | 25.44 |
| Sales Per Share | 35.82 |
| EBITDA (p.s.) | 7.26 |
| Qtrly Earnings Growth | 14.8 % |
| Operating Cash Flow | 534 (M) |
| Levered Free Cash Flow | 215 (M) |
| PE Ratio | 84.14 |
| PEG Ratio | 0 |
| Price to Book value | 14.66 |
| Price to Sales | 8.05 |
| Price to Cash Flow | 38.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|